155 related articles for article (PubMed ID: 486100)
1. Studies on the mechanism of experimental porphyria produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Role of a porphyrin-like inhibitor of protohaem ferro-lyase.
Tephly TR; Gibbs AH; De Matteis F
Biochem J; 1979 Apr; 180(1):241-4. PubMed ID: 486100
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of protohaem ferro-lyase in experimental porphyria. Isolation and partial characterization of a modified porphyrin inhibitor.
De Matteis F; Gibbs AH; Tephly TR
Biochem J; 1980 Apr; 188(1):145-52. PubMed ID: 7406876
[TBL] [Abstract][Full Text] [Related]
3. Decreased liver activity of porphyrin-metal chelatase in hepatic porphyria caused by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Studies in rats and mice.
De Matteis F; Abbritti G; Gibbs AH
Biochem J; 1973 Jul; 134(3):717-27. PubMed ID: 4749272
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of the pathway of porphyrin synthesis in the liver of rats and mice by griseofulvin, 3,5-Diethoxycarbonyl-1,4-dihydrocollidine and related drugs: evidence for two basically different mechanisms.
De Matteis F; Gibbs AH
Biochem J; 1975 Jan; 146(1):285-7. PubMed ID: 1147902
[TBL] [Abstract][Full Text] [Related]
5. Studies on the mechanism of experimental porphyria and ferrochelatase inhibition produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine.
Tephly TR; Gibbs AH; Ingall G; De Matteis F
Int J Biochem; 1980; 12(5-6):993-8. PubMed ID: 7450161
[No Abstract] [Full Text] [Related]
6. The effect of beta-adrenergic blocking agents on experimental porphyria induced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) in vivo and in vitro.
Schoenfeld N; Epstein O; Atsmon A
Biochim Biophys Acta; 1976 Aug; 444(1):286-93. PubMed ID: 8132
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced conversion of liver haem into modified porphyrins. Evidence for two classes of products.
De Matteis F; Gibbs AH
Biochem J; 1980 Apr; 187(1):285-8. PubMed ID: 7406869
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of griseofulvin and 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity in chick embryo liver.
Cole SP; Zelt DT; Marks GS
Mol Pharmacol; 1981 May; 19(3):477-80. PubMed ID: 7266472
[No Abstract] [Full Text] [Related]
9. Ferrochelatase-inhibitory and porphyrin-inducing properties of 3,5-diethoxycarbonyl-1, 4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.
Cole SP; Whitney RA; Marks GS
Mol Pharmacol; 1981 Sep; 20(2):395-403. PubMed ID: 7300820
[No Abstract] [Full Text] [Related]
10. Study of the effects of certain drugs on experimental porphyria in rats.
Deshpande SG; Kandhari KC; Narang BS; Bikhchandani R; Bhutani LK
Dermatologica; 1977; 154(5):284-90. PubMed ID: 863070
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced porphyrin biosynthesis--XIX. Potentiation of the porphyrin-inducing effects of SKF 525-A in the chick embryo liver by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine, an antihibitor of ferrochelatase.
Cole SP; Vavasour EJ; Marks GS
Biochem Pharmacol; 1979 Dec; 28(24):0533-8. PubMed ID: 533555
[No Abstract] [Full Text] [Related]
12. Effect of desferrioxamine and chronic iron deficiency of heme metabolism--comparison with the porphyrogens 2-allyl-2-isopropylacetamide and 3,5-diethoxycarbonyl-1,4-dihydrocollidine.
Liem H; Smith A; Muller-Eberhard U
Biochem Pharmacol; 1979 Jun; 28(11):1753-8. PubMed ID: 475836
[No Abstract] [Full Text] [Related]
13. Ferrochelatase-inhibitory activity and N-alkylprotoporphyrin formation with analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine (DDC) containing extended 4-alkyl groups: implications for the active site of ferrochelatase.
McCluskey SA; Marks GS; Sutherland EP; Jacobsen N; Ortiz de Montellano PR
Mol Pharmacol; 1986 Oct; 30(4):352-7. PubMed ID: 3762522
[TBL] [Abstract][Full Text] [Related]
14. N-Methylprotoporphyrin IX: chemical synthesis and identification as the green pigment produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine treatment.
Ortiz de Montellano PR; Beilan HS; Kunze KL
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1490-4. PubMed ID: 6940170
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of protohaem ferro-lyase by N-substituted porphyrins. Structural requirements for the inhibitory effect.
De Matteis F; Gibbs AH; Smith AG
Biochem J; 1980 Sep; 189(3):645-8. PubMed ID: 7213349
[TBL] [Abstract][Full Text] [Related]
16. The formation of N-alkylprotoporphyrin IX and destruction of cytochrome P-450 in the liver of rats after treatment with 3,5-diethoxycarbonyl-1,4-dihydrocollidine and its 4-ethyl analog.
Coffman BL; Ingall G; Tephly TR
Arch Biochem Biophys; 1982 Oct; 218(1):220-4. PubMed ID: 7149729
[No Abstract] [Full Text] [Related]
17. Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.
Marks GS; Allen DT; Johnston CT; Sutherland EP; Nakatsu K; Whitney RA
Mol Pharmacol; 1985 Apr; 27(4):459-65. PubMed ID: 3982391
[TBL] [Abstract][Full Text] [Related]
18. Strain and sex differences in the response of mice to drugs that induce protoporphyria: role of porphyrin biosynthesis and removal.
Holley A; King LJ; Gibbs AH; De Matteis F
J Biochem Toxicol; 1990; 5(3):175-82. PubMed ID: 2283668
[TBL] [Abstract][Full Text] [Related]
19. PK 11195 aggravates 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced hepatic porphyria in rats.
Fonia O; Weizman R; Coleman R; Kaganovskaya E; Gavish M
Hepatology; 1996 Sep; 24(3):697-701. PubMed ID: 8781345
[TBL] [Abstract][Full Text] [Related]
20. Ribosome function in livers of porphyric mice.
Del Favero A; Gamulin S; Gray CH; Norman MR
Biochem J; 1975 Sep; 150(3):573-6. PubMed ID: 1212209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
